Anxiety, COPD, Depression, Dyspnea, Illness Perception
Conditions
Brief summary
This randomized controlled trial aims to evaluate the effects of hand fan application on dyspnea, illness perception, anxiety, and depression in COPD patients. A total of 56 voluntary COPD patients (28 experimental, 28 control) will be recruited from Ardahan State Hospital Chest Diseases Clinic. Patients will be randomly assigned to the experimental or control group. The experimental group will receive a hand fan and use it for 10 minutes daily for six weeks, while the control group will receive standard care. Dyspnea, illness perception, anxiety, and depression will be assessed using the Visual Dyspnea Scale, Illness Perception Questionnaire, and Hospital Anxiety and Depression Scale at baseline and after six weeks. Data will be analyzed using statistical software. This study is expected to contribute to the literature by evaluating a non-pharmacological intervention for COPD-related dyspnea and psychological outcomes.
Interventions
Participants in the experimental group will be instructed to use a hand fan to cool their face for 10 minutes each day for a period of 6 weeks. The fan should be held approximately 15 cm from the face, focusing on the middle area. This intervention aims to alleviate symptoms of dyspnea and improve psychological well-being, including anxiety, depression, and illness perception. The participants will receive daily reminders to ensure consistent application of the intervention.
Participants in the control group will receive standard care for chronic obstructive pulmonary disease (COPD) patients. This includes routine management and treatment as prescribed by their healthcare providers, such as medication and lifestyle recommendations. They will not be instructed to use a hand fan or any other cooling device during the study period. The control group will continue their regular care without any additional interventions from the research team.
Sponsors
Study design
Masking description
Blinding will be done for the researcher, participants and statistician.
Eligibility
Inclusion criteria
* Orientation and cooperation * No communication problems
Exclusion criteria
* Having a COPD exacerbation in the last 4 weeks
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Dyspnea Severity | Pre-intervention: Before the start of the intervention (baseline measurement).Post-intervention: After 6 weeks of intervention (final measurement). | The primary outcome measure of this study will be the severity of dyspnea, assessed using the Visual Analog Scale (VAS). This scale is a subjective tool used to measure the intensity of shortness of breath experienced by participants. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Illness Perception | Pre-intervention: Before the start of the intervention (baseline measurement).Post-intervention: After 6 weeks of intervention (final measurement). | Measured using the Illness Perception Questionnaire |
| Anxiety and Depression | Pre-intervention: Before the start of the intervention (baseline measurement).Post-intervention: After 6 weeks of intervention (final measurement). | Measured using the Hospital Anxiety and Depression Scale (HADS) |
Countries
Turkey (Türkiye)